Invesco’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $359K | Sell |
21,141
-457
| -2% | -$7.77K | ﹤0.01% | 3275 |
|
|
2025
Q4 | $405K | Buy |
21,598
+2,799
| +15% | +$42.2K | ﹤0.01% | 3280 |
|
|
2025
Q3 | $240K | Buy |
18,799
+1,431
| +8% | +$21.5K | ﹤0.01% | 3505 |
|
|
2025
Q2 | $292K | Buy |
17,368
+1,022
| +6% | +$13.8K | ﹤0.01% | 3373 |
|
|
2025
Q1 | $209K | Buy |
16,346
+371
| +2% | +$5.95K | ﹤0.01% | 3495 |
|
|
2024
Q4 | $282K | Buy |
15,975
+52
| +0.3% | +$986 | ﹤0.01% | 3431 |
|
|
2024
Q3 | $364K | Sell |
15,923
-264,660
| -94% | -$5.98M | ﹤0.01% | 3350 |
|
|
2024
Q2 | $6.44M | Sell |
280,583
-86,028
| -23% | -$2.65M | ﹤0.01% | 2054 |
|
|
2024
Q1 | $14.5M | Buy |
366,611
+345,079
| +1,603% | +$13.6M | ﹤0.01% | 1609 |
|
|
2023
Q4 | $852K | Buy |
21,532
+1,307
| +6% | +$54.7K | ﹤0.01% | 2965 |
|
|
2023
Q3 | $897K | Sell |
20,225
-14,834
| -42% | -$647K | ﹤0.01% | 2916 |
|
|
2023
Q2 | $1.53M | Buy |
35,059
+16,139
| +85% | +$710K | ﹤0.01% | 2725 |
|
|
2023
Q1 | $823K | Sell |
18,920
-4,642
| -20% | -$205K | ﹤0.01% | 2994 |
|
|
2022
Q4 | $879K | Buy |
23,562
+1,228
| +5% | +$47.5K | ﹤0.01% | 2994 |
|
|
2022
Q3 | $889K | Buy |
22,334
+342
| +2% | +$12.7K | ﹤0.01% | 2972 |
|
|
2022
Q2 | $842K | Sell |
21,992
-839
| -4% | -$30.3K | ﹤0.01% | 3063 |
|
|
2022
Q1 | $905K | Buy |
22,831
+2,822
| +14% | +$110K | ﹤0.01% | 3117 |
|
|
2021
Q4 | $830K | Buy |
20,009
+4,209
| +27% | +$183K | ﹤0.01% | 3166 |
|
|
2021
Q3 | $666K | Buy |
15,800
+1,514
| +11% | +$76.2K | ﹤0.01% | 3294 |
|
|
2021
Q2 | $656K | Buy |
14,286
+1,403
| +11% | +$66.7K | ﹤0.01% | 3297 |
|
|
2021
Q1 | $604K | Buy |
12,883
+5,232
| +68% | +$254K | ﹤0.01% | 3273 |
|
|
2020
Q4 | $327K | Buy |
7,651
+1,819
| +31% | +$93.4K | ﹤0.01% | 3383 |
|
|
2020
Q3 | $287K | Sell |
5,832
-13,655
| -70% | -$756K | ﹤0.01% | 3337 |
|
|
2020
Q2 | $1.13M | Buy |
19,487
+1,376
| +8% | +$72.7K | ﹤0.01% | 2750 |
|
|
2020
Q1 | $823K | Sell |
18,111
-19,992
| -52% | -$1.2M | ﹤0.01% | 2809 |
|
|
2019
Q4 | $2.51M | Sell |
38,103
-1,856
| -5% | -$113K | ﹤0.01% | 2541 |
|
|
2019
Q3 | $2.31M | Buy |
39,959
+24,681
| +162% | +$1.53M | ﹤0.01% | 2551 |
|
|
2019
Q2 | $880K | Buy |
15,278
+4,607
| +43% | +$213K | ﹤0.01% | 3129 |
|
|
2019
Q1 | $412K | Buy |
+10,671
| New | +$418K | ﹤0.01% | 3379 |
|
|
2018
Q3 | – | Sell |
-5,714
| Closed | -$214K | – | 3911 |
|
|
2018
Q2 | $214K | Sell |
5,714
-31,386
| -85% | -$1.09M | ﹤0.01% | 3685 |
|
|
2018
Q1 | $1.08M | Buy |
37,100
+31,381
| +549% | +$1.05M | ﹤0.01% | 2994 |
|
|
2017
Q4 | $213K | Sell |
5,719
-9
| -0.2% | -$320 | ﹤0.01% | 3523 |
|
|
2017
Q3 | $216K | Buy |
+5,728
| New | +$180K | ﹤0.01% | 3534 |
|
|
2015
Q3 | – | Sell |
-381
| Closed | -$5K | – | 3925 |
|
|
2015
Q2 | $5K | Buy |
+381
| New | +$5.4K | ﹤0.01% | 4209 |
|
Other funds holding NRC
VCM
QI
Invesco's NRC Position: Q1 2026 in Review
Invesco reduced its NRC Health Common Stock (NRC) stake by 2.1% in Q1 2026, selling an estimated $7.77K and leaving 21,141 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #3275.
Invesco first reported a position in NRC in Q2 2015 and has held it in 34 quarters since. The position peaked at $14.5M in Q1 2024. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.
- Invesco held 21,141 shares of NRC Health Common Stock worth $359K as of Q1 2026.
- Invesco sold 457 NRC Health Common Stock shares in Q1 2026, an estimated $7.77K.
- NRC Health Common Stock made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3275 holding.
- Invesco first reported a position in NRC Health Common Stock in Q2 2015 and has held it in 34 quarters since.
- Invesco's NRC Health Common Stock position peaked at $14.5M in Q1 2024.
- 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.